Literature DB >> 1320101

Detection of enteroviruses in endomyocardial biopsy by molecular approach.

J Petitjean1, H Kopecka, F Freymuth, J M Langlard, P Scanu, F Galateau, J B Bouhour, M Ferrière, P Charbonneau, M Komajda.   

Abstract

Enteroviruses are considered to be the most common agents implicated in myocarditis and cardiomyopathy. Recent studies have suggested persistent enterovirus infection in chronic disease showing the presence of enteroviral RNA in the myocardium. We used gene amplification by PCR which can demonstrate directly the presence of enteroviral sequences in endomyocardial biopsies. The primers were chosen in the 5' non-coding region of the genome representing highly conserved sequences among enteroviruses and therefore allowed the amplification of the majority of enteroviruses. The hybridization of the amplified products was effected with specific general riboprobe derived from 5' non-coding sequences internal of the amplified fragments. The results include 105 patients distributed in 6 groups: 45 idiopathic dilated cardiomyopathies with 66.7%, 17 alcoholic cardiomyopathies with 52.9%, 10 myocarditis with 30%, 5 multifactorial cardiomyopathies with 40%, 5 patients with immunosuppressive therapy with 100%, and 23 control group without viral etiology with 39.1% positive samples. The study suggested a positive link between viral infection and cardiomyopathies, but did not allow a direct relation between enterovirus infection and idiopathic dilated cardiomyopathy to be established.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320101     DOI: 10.1002/jmv.1890370114

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

1.  Absence of viral nucleic acids in early and late dilated cardiomyopathy.

Authors:  N G Mahon; B Zal; G Arno; P Risley; J Pinto-Basto; W J McKenna; M J Davies; C Baboonian
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

2.  Detection of enteroviruses and rhinoviruses in clinical specimens by PCR and liquid-phase hybridization.

Authors:  P Halonen; E Rocha; J Hierholzer; B Holloway; T Hyypiä; P Hurskainen; M Pallansch
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

Review 3.  Link between enteroviruses and dilated cardiomyopathy: serological and molecular data.

Authors:  P J Keeling; S Tracy
Journal:  Br Heart J       Date:  1994-12

4.  Meta-analysis of the association of enteroviruses with human heart disease.

Authors:  C Baboonian; T Treasure
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

5.  The role of viral infections in the development of dilated cardiomyopathy.

Authors:  Eniko Tátrai; István Hartyánszky; András Lászik; György Acsády; Péter Sótonyi; Márta Hubay
Journal:  Pathol Oncol Res       Date:  2010-09-18       Impact factor: 3.201

6.  Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy.

Authors:  Ulrich Lotze; Renate Egerer; Christiane Tresselt; Brigitte Glück; Gudrun Dannberg; Axel Stelzner; Hans R Figulla
Journal:  Med Microbiol Immunol       Date:  2003-12-20       Impact factor: 3.402

7.  Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.

Authors:  H Zhang; G E Yousef; X Ouyang; L C Archard
Journal:  Int J Exp Pathol       Date:  1994-04       Impact factor: 1.925

Review 8.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

9.  Nested PCR for specific detection and rapid identification of human picornaviruses.

Authors:  U Kämmerer; B Kunkel; K Korn
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

10.  Rapid diagnosis of enterovirus infection by magnetic bead extraction and polymerase chain reaction detection of enterovirus RNA in clinical specimens.

Authors:  P Muir; F Nicholson; M Jhetam; S Neogi; J E Banatvala
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.